UMVCUE

  • 文章类型: Journal Article
    临床研究中面临的一个常见问题是估计k(≥2)种可用治疗中最有效(例如具有最大平均)治疗的效果。根据与k种处理相对应的一些统计量的数值来判断最有效的处理。针对此类问题的适当设计是所谓的“丢弃失败者设计(DLD)”。我们考虑两种治疗方法,其效果由具有不同未知均值和共同已知方差的独立高斯分布描述。为了选择更有效的治疗方法,将两种治疗各自独立地给予n1个受试者,并且选择对应于较大样本平均值的治疗。为了研究判定的更有效治疗的效果(即估计其平均值),我们考虑两阶段DLD,其中n2受试者在设计的第二阶段被认为是更有效的治疗.我们获得了一些可容许性和最小性结果,以估计所判定的更有效治疗的平均效果。最大似然估计器显示为minimax且可允许。我们证明了所选治疗均值的均匀最小方差条件无偏估计器(UMVCUE)是不可接受的,并获得了改进的估计器。在这个过程中,我们还得出了任意位置和置换等变估计器不可接受性的充分条件,并在某些情况下提供了主导估计器,在满足这个充分条件的情况下。通过仿真研究比较了各种竞争估计器的均方误差和偏差性能。为了说明的目的,还提供了真实的数据示例。
    A common problem faced in clinical studies is that of estimating the effect of the most effective (e.g. the one having the largest mean) treatment among k(≥2) available treatments. The most effective treatment is adjudged based on numerical values of some statistic corresponding to the k treatments. A proper design for such problems is the so-called \"Drop-the-Losers Design (DLD)\". We consider two treatments whose effects are described by independent Gaussian distributions having different unknown means and a common known variance. To select the more effective treatment, the two treatments are independently administered to n1 subjects each and the treatment corresponding to the larger sample mean is selected. To study the effect of the adjudged more effective treatment (i.e. estimating its mean), we consider the two-stage DLD in which n2 subjects are further administered the adjudged more effective treatment in the second stage of the design. We obtain some admissibility and minimaxity results for estimating the mean effect of the adjudged more effective treatment. The maximum likelihood estimator is shown to be minimax and admissible. We show that the uniformly minimum variance conditionally unbiased estimator (UMVCUE) of the selected treatment mean is inadmissible and obtain an improved estimator. In this process, we also derive a sufficient condition for inadmissibility of an arbitrary location and permutation equivariant estimator and provide dominating estimators in cases, where this sufficient condition is satisfied. The mean squared error and the bias performances of various competing estimators are compared via a simulation study. A real data example is also provided for illustration purpose.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    当在随机对照研究中采用固定试验设计时,通过回归方法进行的协变量调整可以提高统计推断的精度。当采用具有选择治疗能力的自适应多臂设计时,目前尚不清楚协变量调整如何影响研究的各个方面.考虑依赖于预先指定的治疗选择规则和用于假设检验的组合检验方法的设计框架。我们的主要目标是评估协变量调整对具有治疗选择的自适应多臂设计的影响。我们的次要目标是显示如何扩展均匀最小方差条件无偏估计器,以分析地考虑协变量调整。我们发现,对不同组的协变量进行调整会导致不同的治疗选择结果,从而导致拒绝假设的可能性。然而,当协变量包含在分析模型中时,我们看不到对家族错误率控制的任何负面影响.当调整与结果中等或高度相关的协变量时,我们看到了分析设计的各种好处。相反,当包括与结果不相关的协变量时,影响可以忽略不计.总的来说,建议对协变量调整进行预规范,以分析具有治疗选择的自适应多臂设计。在中期和最终分析之前制定统计分析计划至关重要,特别是当在试验中考虑治疗效果的非可折叠测量时.
    Covariate adjustment via a regression approach is known to increase the precision of statistical inference when fixed trial designs are employed in randomized controlled studies. When an adaptive multi-arm design is employed with the ability to select treatments, it is unclear how covariate adjustment affects various aspects of the study. Consider the design framework that relies on pre-specified treatment selection rule(s) and a combination test approach for hypothesis testing. It is our primary goal to evaluate the impact of covariate adjustment on adaptive multi-arm designs with treatment selection. Our secondary goal is to show how the Uniformly Minimum Variance Conditionally Unbiased Estimator can be extended to account for covariate adjustment analytically. We find that adjustment with different sets of covariates can lead to different treatment selection outcomes and hence probabilities of rejecting hypotheses. Nevertheless, we do not see any negative impact on the control of the familywise error rate when covariates are included in the analysis model. When adjusting for covariates that are moderately or highly correlated with the outcome, we see various benefits to the analysis of the design. Conversely, there is negligible impact when including covariates that are uncorrelated with the outcome. Overall, pre-specification of covariate adjustment is recommended for the analysis of adaptive multi-arm design with treatment selection. Having the statistical analysis plan in place prior to the interim and final analyses is crucial, especially when a non-collapsible measure of treatment effect is considered in the trial.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    The two-stage drop-the-loser design provides a framework for selecting the most promising of K experimental treatments in stage one, in order to test it against a control in a confirmatory analysis at stage two. The multistage drop-the-losers design is both a natural extension of the original two-stage design, and a special case of the more general framework of Stallard & Friede () (Stat. Med. 27, 6209-6227). It may be a useful strategy if deselecting all but the best performing treatment after one interim analysis is thought to pose an unacceptable risk of dropping the truly best treatment. However, estimation has yet to be considered for this design. Building on the work of Cohen & Sackrowitz () (Stat. Prob. Lett. 8, 273-278), we derive unbiased and near-unbiased estimates in the multistage setting. Complications caused by the multistage selection process are shown to hinder a simple identification of the multistage uniform minimum variance conditionally unbiased estimate (UMVCUE); two separate but related estimators are therefore proposed, each containing some of the UMVCUEs theoretical characteristics. For a specific example of a three-stage drop-the-losers trial, we compare their performance against several alternative estimators in terms of bias, mean squared error, confidence interval width and coverage.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号